Trade Pfizer ^PFE

Celcuity Adds Oncology Veteran To Board As Gedatolisib Commercial Stakes Rise

Sciwind Biosciences Partners with Pfizer China to Commercialize its Biased GLP-1 in China | Morningstar

Pfizer in diabetes drug deal with Sciwind Biosciences

How Breakwater Trial Data At Pfizer (PFE) Has Changed Its Oncology Investment Story

Sciwind Biosciences partners with Pfizer China to commercialise Biased GLP-1 in China in $495 M deal

Key factors for implementing inhaler regimen switches in respiratory diseases: international expert consensus generated using a modified nominal group technique (NGT)

Best Pharmaceutical Stocks To Follow Today - February 22nd - Markets Daily

Top Medical Stocks To Consider - February 20th - Markets Daily

Assessing Pfizer (PFE) Valuation As Investors Revisit Mixed Returns And Oncology Growth Prospects

Inspire Trust Co. N.A. Has $3.82 Million Stock Holdings in Pfizer Inc. $PFE - Daily Political

PFE: Obesity Pipeline Progress Will Drive Post LOE Re Rating

Stevens Capital Management LP Makes New Investment in Pfizer Inc. $PFE

Barclays Upgrades Pfizer (NYSE:PFE) to "Strong Sell"

GSA Capital Partners LLP Boosts Holdings in Pfizer Inc. $PFE - Stock Observer

Jupiter Asset Management Ltd. Raises Holdings in Pfizer Inc. $PFE

Glucagon-like Peptide 1 (GLP-1) Market Report 2026-2035: Market to Reach $33.26 Billion by 2030 - Oral Formulations and Long-Acting Peptides Accelerate Next-Gen Obesity and Diabetes Therapies

Sexual Health Supplement Market Report 2026-2035: Market to Reach $5.31 Billion by 2030, Driven by Biotechnology Innovation, Transparency in Ingredient Traceability and Gender-Specific Expansion

Dactinomycin Market Research Report 2026-2030 & 2035: $7.83 Billion Market Driven by Expansion of Cancer Centers, Emphasis on Pediatric Oncology, and Combination Therapy Research

Pfizer Inc (PFE) Announces Positive Results from BREAKWATER Trial

Pfizer Inc. $PFE Shares Acquired by Wealth Alliance LLC - Daily Political

BioNTech Takes Legal Action Against Moderna for COVID Vaccine Patent Infringement, ETPharma

Artificial intelligence-generated synthetic data for cancer research and clinical trials

Evolving roles of liquid biopsy in precision medicine for colorectal cancer: from single-gene analysis to broad genomic profiling

Pfizer (NYSE:PFE) Shares Down 1.8% - Should You Sell?

Pfizer Oncology And Rare Disease Milestones Shape Long Term Growth Prospects

Axxcess Wealth Management LLC Boosts Stake in Pfizer Inc. $PFE

Valneva publie son chiffre d'affaires et sa trésorerie non audités pour l'exercice 2025 et fournit ses prévisions pour l'exercice 2026

Bispecific T cell engagers for treatment-refractory autoimmune connective tissue diseases

Pfizer Colorectal Cancer Trial Win Adds Weight To Oncology Turnaround Story

Pfizer Inc. $PFE Shares Sold by Essex Financial Services Inc. - Markets Daily

Fallopian Tube Cancer Market Research Report 2026: AstraZeneca, GlaxoSmithKline, Pfizer and Roche Expand Portfolios and Invest in Novel Therapeutics & Companion Diagnostics - Forecasts 2025-2035

Essex Financial Services Inc. Trims Stock Holdings in Pfizer Inc. $PFE - Stock Observer

ADPT: Pfizer Agreements And MRD Progress Will Support Future Upside Potential

Pfizer Inc. $PFE Shares Sold by Skandinaviska Enskilda Banken AB publ - Stock Observer

CenterBook Partners LP Has $12.65 Million Stock Holdings in Pfizer Inc. $PFE - Daily Political

Navigating drug-drug interactions with apalutamide

M&G PLC Lowers Stock Holdings in Pfizer Inc. $PFE

HighTower Advisors LLC Sells 27,391 Shares of Pfizer Inc. $PFE - Daily Political

How to integrate steatotic liver disease screening and treatment into clinical care

The evolution to hepta-refractory myeloma involves sequential loss of CD38, BCMA and GPRC5D

PNC Financial Services Group Inc. Sells 223,165 Shares of Pfizer Inc. $PFE - Stock Observer

Fifth Third Bancorp Sells 93,615 Shares of Pfizer Inc. $PFE - Stock Observer

Top Pharmaceutical Stocks To Watch Now - February 15th - Stock Observer

Pfizer Inc. $PFE Shares Bought by State of New Jersey Common Pension Fund D

TCTC Holdings LLC Reduces Stock Holdings in Pfizer Inc. $PFE

Pfizer Inc. $PFE Shares Bought by GF Fund Management CO. LTD. - Markets Daily

Pfizer Inc. $PFE Shares Bought by Aberdeen Group plc

Pfizer (NYSE:PFE) Cut to Hold at Daiwa America - Daily Political

Oric Pharmaceuticals Highlights 2025 Milestones at Guggenheim, Targets Phase 3 Prostate Trial in 1H25 - Stock Observer

Assetmark Inc. Buys 193,859 Shares of Pfizer Inc. $PFE

Daiwa Downgrades Pfizer (PFE) to Neutral Following Full-Year 2025 Earnings

Pfizer Inc. $PFE Shares Purchased by Public Sector Pension Investment Board - Daily Political

Metis Global Partners LLC Trims Stake in Pfizer Inc. $PFE - Daily Political

Pfizer Obesity And Hemophilia Advances Spark Fresh Interest In Valuation

Is Pfizer Inc. (PFE) One of the Best Medical Research Stocks to Buy According to Hedge Funds?

Pfizer (NYSE:PFE) Downgraded by Daiwa America to Hold - Markets Daily

Pfizer Hemophilia And Obesity Updates Add Context To Valuation Debate

Versor Investments LP Sells 37,800 Shares of Pfizer Inc. $PFE

Pfizer (NYSE:PFE) Lowered to "Hold" Rating by Daiwa America

Pfizer Inc. $PFE Shares Sold by Prospera Financial Services Inc

CENTRAL TRUST Co Has $10.19 Million Position in Pfizer Inc. $PFE - Markets Daily

Illinois Municipal Retirement Fund Cuts Stake in Pfizer Inc. $PFE

Pfizer Inc. $PFE Position Cut by CENTRAL TRUST Co - Stock Observer

GFS Advisors LLC Has $10.49 Million Position in Pfizer Inc. $PFE - Stock Observer

Kahn Brothers Reduces Stake in Pfizer Inc by 21.66%

Pfizer (NYSE:PFE) Lowered to Neutral Rating by Daiwa Securities Group - Markets Daily

ING Groep NV Sells 72,193 Shares of Pfizer Inc. $PFE - Markets Daily

India's MedTech Startups: Innovations and Challenges in High-Tech Healthcare, ETHealthworld

Pharmaceutical Stocks To Watch Today - February 12th - Stock Observer

Pfizer (NYSE:PFE) Cut to Neutral at Daiwa Securities Group

Here Are Thursday's Top Wall Street Analyst Research Calls: BP Plc., Borg Warner, Generac, Kraft-Heinz, MercadoLibre, Pfizer, Shopify, Valvoline, and More

Pfizer Inc. $PFE Shares Purchased by LSV Asset Management

FTAs open up 70% of global GDP to India, largely at zero duty, says Piyush Goyal

Caprock Group LLC Makes New Investment in Pfizer Inc. $PFE

ING Groep NV Lowers Holdings in Pfizer Inc. $PFE - Stock Observer

Madison Asset Management LLC Has $6.17 Million Stock Position in Pfizer Inc. $PFE - Stock Observer

RFG Advisory LLC Has $1.27 Million Stock Position in Pfizer Inc. $PFE - Daily Political

Pfizer shares climb 13% in 3 days post Q3 results; is more steam left?

Disease progression patterns and association of prostate-specific antigen level with risk of progression in nonmetastatic castration-resistant prostate cancer

UK law firms consider action on behalf of women who developed brain tumours after using contraceptive

Pfizer Balances New Therapies And Pricing With Fresh Biotech Partnerships

Hedge Fund and Insider Trading News: Steven Cohen, Ray Dalio, Ken Griffin, Bill Ackman, Warren Buffett, Elliott Management, L1 Capital, Nextera Energy Inc (NEE), TransDigm Group Inc (TDG), and More

Pfizer Inc. $PFE Shares Sold by Oppenheimer Asset Management Inc.

Pfizer Inc. $PFE Shares Bought by Advisors Asset Management Inc.

FDA refuses to review Moderna's application for mRNA flu vaccine, company says | CNN

Pfizer Gets $29 Million of SAC Capital Insider Trade SEC Payout

Pfizer (NYSE:PFE) Sets New 1-Year High - Still a Buy?

Pfizer (NYSE:PFE) Shares Up 2.1% - Still a Buy?

Top Pharmaceutical Stocks To Consider - February 10th - Markets Daily

Promising Pharmaceutical Stocks To Watch Now - February 9th - Daily Political

Pfizer Inc. (PFE) Announces FDA's Grant of Priority Review for HYMPAVZI® (marstacimab) sBLA

EZH2 Targeted Therapy Market Research 2026: Ipsen Leads With Tazverik, Hengrui and Pfizer Advance Next-Generation EZH2 Programs - Opportunities, Approved Drug Prices, Sales, Clinical Trials Insights

Pfizer Standalone December 2025 Net Sales at Rs 645.03 crore, up 19.9% Y-o-Y

3 Vanguard ETFs to watch in 2026: VTV ETF, MGV ETF, VOO ETF

NVIDIA (NVDA) Stock Price & Overview 2026: What is Nvidia stock prediction?

Bitcoin slips under $63K: Will BTC price keep going down in 2026?

Novo Nordisk (NVO) stock analysis: Novo shares drop 16%, what’s next for NVO?

Commodity market today: gold (XAU/USD) and sliver dropped, what’s next?

Dividend Stocks and Investing: What are the most popular dividend stocks in 2026?

Bitcoin (BTCUSD) is seeing a modest rise: Is BTC about to reverse and head lower?

Alphabet (GOOG) stock is trading down: What’s happening with Alphabet Inc.?

Gold price forecast: XAU/USD remains under $5000, what’s next?

Michael Burry Bets Against Nvidia & Palantir Amid AI Boom: A Bubble?

ESMA Expansion Sparks Crypto, Fintech Slowdown Concerns in EU

Bitcoin's 'Santa' Rally: Fed Rate Decision and 2026 Outlook

Western Union Unveils Stable Card, Stablecoin Strategy to Combat Inflation

Market Movers: Fed Rate Decision & Key Economic Data in Focus Next Week

Central Bank Rate Decisions & Market Volatility Outlook: What to Expect

Clear Street Prepares for IPO Amid Crypto Treasury Model Concerns

Crypto Market Analysis and Regulatory Updates: December 6, 2024

Bitcoin Treasury Firms Face 'Darwinian Phase' Amid Market Shift